CHU de la Timone

Marseille 13385

0 studies enrolling now · 7 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Atrial Fibrillation, Bladder Cancer, Carcinoma, Non-Small-Cell Lung, Late-onset Pompe Disease, Metastatic Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

Studies at this site

• A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases — Completed
• BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study) — Stopped early
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed